POST COVID-19 CONDITION, UNSPECIFIED

Clinical trials for POST COVID-19 CONDITION, UNSPECIFIED explained in plain language.

Never miss a new study

Get alerted when new POST COVID-19 CONDITION, UNSPECIFIED trials appear

Sign up with your email to follow new studies for POST COVID-19 CONDITION, UNSPECIFIED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Race to stop long COVID: major trial tests common drug

Prevention Ongoing

This large study is testing if taking the antiviral drug Paxlovid for a short time right after getting COVID-19 can prevent people from developing long-lasting symptoms, known as long COVID. About 2,000 adults in Norway with recent, confirmed COVID-19 will take either Paxlovid or…

Matched conditions: POST COVID-19 CONDITION, UNSPECIFIED

Phase: PHASE3 • Sponsor: Haukeland University Hospital • Aim: Prevention

Last updated Mar 30, 2026 14:30 UTC

POST COVID-19 CONDITION, UNSPECIFIED

Get alerted when new POST COVID-19 CONDITION, UNSPECIFIED trials appear

Race to stop long COVID: major trial tests common drug